Adriana Trajtman

Adriana Trajtman

Auto-generated profile, based on publicly available information

Adriana Trajtman

Department of Pediatrics, University of Manitoba, Winnipeg, Manitoba

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
Breanne HeadBreanne Head
Breanne Head
ATAdriana Trajtman
Adriana Trajtman
KBKathryn Bernard
Kathryn Bernard
TBTamara Burdz
Tamara Burdz
LVLázaro Vélez
Lázaro Vélez
YKYoav Keynan
Yoav Keynan

1 June 2015 in Cytokine
Verified
Journal Article
Open access
YKYoav Keynan
Yoav Keynan
ZRZulma Vanessa Rueda
Zulma Vanessa Rueda
YAYudy Aguilar
Yudy Aguilar
ATAdriana Trajtman
Adriana Trajtman
LVLázaro A. Vélez
Lázaro A. Vélez
We wanted to investigate the pro-inflammatory cytokine/chemokine profile associated with the etiological agents identified in HIV patients. Immunosuppressed patients admitted to two hospitals in Medellin, Colombia, with clinical and radiographic diagnosis of pneumonia were enrolled in the study. After consent, bronchoalveolar lavage (BAL) was collected for bacterial, mycobacterial and fungal diagnosis. All patients were followed for a year. A stored BAL sample was used for cytokine/chemokine detection and measurement using commercial, magnetic human cytokine bead-based 19-plex assays. Statistical analysis was performed by assigning cytokine/chemokine concentrations levels into 75 percentile (higher). Principal component analysis (PCA) and Kruskal-Wallis analysis were conducted to identify the clustering of cytokines with the various infectious etiologies (fungi, Mycobacterium tuberculosis - MTB, and bacteria). Average age of patients was 35, of whom 77% were male, and the median CD4 count of 33cells/μl. Of the 57 HIV infected patients, in-hospital mortality was 12.3% and 33% died within a year of follow up. The PCA revealed increased IL-10, IL-12, IL-13, IL-17, Eotaxin, GCSF, MIP-1α, and MIP-1β concentrations to be associated with MTB infection. In patients with proven fungal infection, low concentrations of IL-1RA, IL-8, TNF-α and VEGF were identified. Bacterial infections displayed a distinct cytokine pattern and were not misclassified using the MTB or fungi cytokine patterns (p-value<0.0001). Our results indicate a unique pattern of pro-inflammatory cytokine/chemokine, allowing differentiation between bacterial and non-bacterial pathogens. Moreover, we found distinct, if imperfectly discriminatory, cytokine/chemokine patterns associated with MTB and fungal infections.

23 February 2021 in medRxiv
Verified
Preprint
Open access
PDF file
MBMichelle Barton
Michelle Barton
JPJesse Papenburg
Jesse Papenburg
Rolando Ulloa-GutierrezRolando Ulloa-Gutierrez
Rolando Ulloa-Gutierrez
HBHelena Brenes-Chacon
Helena Brenes-Chacon
Adriana Yock-CorralesAdriana Yock-Corrales
Adriana Yock-Corrales
JRJoan Louise Robinson
Joan Louise Robinson
Background A cohort study was conducted to describe and compare the characteristics of SARS-CoV-2 infection in hospitalized children in three countries. Methods This was a retrospective cohort of consecutive children admitted to 15 hospitals (13 in Canada and one each in Iran and Costa Rica) up to November 16, 2020. Cases were included if they had SARS-CoV-2 infection or multi-system inflammatory syndrome in children (MIS-C) with molecular detection of SARS-CoV-2 or positive SARS-CoV-2 serology. Results Of 211 included cases (Canada N=95; Costa Rica N=84; Iran N=32), 103 (49%) had a presumptive diagnosis of COVID-19 or MIS-C at admission while 108 (51%) were admitted with other diagnoses. Twenty-one (10%) of 211 met criteria for MIS-C. Eighty-seven (41%) had comorbidities. Children admitted in Canada were older than those admitted to non-Canadian sites (median 4.1 versus 2.2 years; p<0.001) and less likely to require mechanical ventilation (3/95 [3%] versus 15/116 [13%]; p<0.05). Sixty-four of 211 (30%) required supplemental oxygen or intensive care unit (ICU) admission and 4 (1.9%) died. Age < 30 days, admission outside Canada, presence of at least one comorbidity and chest imaging compatible with COVID-19 predicted severe or critical COVID-19 (defined as death or need for supplemental oxygen or ICU admission). Conclusions Approximately half of hospitalized children with confirmed SARS-CoV-2 infection or MIS-C were admitted with other suspected diagnoses. Disease severity was higher at non-Canadian sites. Neonates, children with comorbidities and those with chest radiographs compatible with COVID-19 were at increased risk for severe or critical COVID-19. Main points Approximately half of hospitalized children with laboratory confirmed MIS-C or SARS-CoV-2 infection were admitted with another primary diagnoses. The severity of disease was higher in the middle income countries (Costa Rica and Iran) than in Canada.